Live Variola Virus: Considerations for Continuing Research (2009)

Chapter: 6 Development of Therapeutics

Unfortunately, this book can't be printed from the OpenBook. If you need to print pages from this book, we recommend downloading it as a PDF.

Visit NAP.edu/10766 to get more information about this book, to buy it in print, or to download it as a free PDF.
Previous Chapter: 5 Genomic Analysis
Page 67 Cite Bookmark
Suggested Citation: "6 Development of Therapeutics." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Save
Cancel
Page 67
Page 68 Cite Bookmark
Suggested Citation: "6 Development of Therapeutics." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Save
Cancel
Page 68
Page 69 Cite Bookmark
Suggested Citation: "6 Development of Therapeutics." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Save
Cancel
Page 69
Page 70 Cite Bookmark
Suggested Citation: "6 Development of Therapeutics." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Save
Cancel
Page 70
Page 71 Cite Bookmark
Suggested Citation: "6 Development of Therapeutics." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Save
Cancel
Page 71
Page 72 Cite Bookmark
Suggested Citation: "6 Development of Therapeutics." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Save
Cancel
Page 72
Page 73 Cite Bookmark
Suggested Citation: "6 Development of Therapeutics." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Save
Cancel
Page 73
Page 74 Cite Bookmark
Suggested Citation: "6 Development of Therapeutics." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Save
Cancel
Page 74
Page 75 Cite Bookmark
Suggested Citation: "6 Development of Therapeutics." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Save
Cancel
Page 75
Page 76 Cite Bookmark
Suggested Citation: "6 Development of Therapeutics." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Save
Cancel
Page 76
Page 77 Cite Bookmark
Suggested Citation: "6 Development of Therapeutics." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Save
Cancel
Page 77
Page 78 Cite Bookmark
Suggested Citation: "6 Development of Therapeutics." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Save
Cancel
Page 78
Page 79 Cite Bookmark
Suggested Citation: "6 Development of Therapeutics." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Save
Cancel
Page 79
Page 80 Cite Bookmark
Suggested Citation: "6 Development of Therapeutics." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Save
Cancel
Page 80
Page 81 Cite Bookmark
Suggested Citation: "6 Development of Therapeutics." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Save
Cancel
Page 81
Page 82 Cite Bookmark
Suggested Citation: "6 Development of Therapeutics." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Save
Cancel
Page 82
Page 83 Cite Bookmark
Suggested Citation: "6 Development of Therapeutics." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Save
Cancel
Page 83
Page 84 Cite Bookmark
Suggested Citation: "6 Development of Therapeutics." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Save
Cancel
Page 84
Page 85 Cite Bookmark
Suggested Citation: "6 Development of Therapeutics." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Save
Cancel
Page 85
Page 86 Cite Bookmark
Suggested Citation: "6 Development of Therapeutics." Institute of Medicine. 2009. Live Variola Virus: Considerations for Continuing Research. Washington, DC: The National Academies Press. doi: 10.17226/12616.
Save
Cancel
Page 86
Next Chapter: 7 Development of Vaccines
Subscribe to Email from the National Academies
Keep up with all of the activities, publications, and events by subscribing to free updates by email.